Close RECOMMEND
Ken Kam

Ken Kam |Contributor

I require these “Marketocracy Masters” to outperform the S&P 500 for a minimum of 5 years before their model portfolios are used for clients with separately managed accounts. Before Marketocracy, I was the CEO and co-founder of Firsthand Funds; co-portfolio manager of the Technology Value Fund (the number one fund in the country for its first three and five years); and co-founder of Novoste Corporation, a medical products company now owned by Boston Scientific.

I am the CEO and founder of Marketocracy, Inc., and portfolio manager at Marketocracy Capital Management, LLC, an innovative technology based firm that maintains a database of the world’s greatest “unknown” investors.